Nelson Arlin D 4

4 · MERIT MEDICAL SYSTEMS INC · Filed Sep 25, 2009

Form 4

Period: 2009-09-23

Chief Operating Officer

Transactions

Exercise/Conversion
Non-qualified Stock Options (right to buy)
2009-09-23−8,335→ 0 total
Exercise: $2.07From: 2001-02-12Exp: 2011-02-12→ Common Stock (8,335 underlying)
Sale
Common Stock, No Par Value
2009-09-23$17.79/sh−8,335$148,242→ 0 total
Exercise/Conversion
Common Stock, No Par Value
2009-09-23$2.07/sh+8,335$17,253→ 8,335 total

Holdings

Common Stock, No Par Value
(indirect: By 401(k))
864
Non-qualified Stock Options (right to buy)
Exercise: $9.74From: 2003-02-06Exp: 2013-02-06→ Common Stock (8,889 underlying)
8,889
Non-qualified Stock Options (right to buy)
Exercise: $12.14From: 2005-12-28Exp: 2015-12-28→ Common Stock (10,000 underlying)
10,000
Non-qualified stock options (right to buy)
Exercise: $14.41From: 2009-05-21Exp: 2015-05-21→ Common Stock (25,000 underlying)
25,000
Non-qualified Stock Options (right to buy)
Exercise: $13.81From: 2004-06-10Exp: 2014-06-10→ Common Stock (1,500 underlying)
1,500
Non-qualified Stock Options (right to buy)
Exercise: $12.13From: 2008-06-27Exp: 2014-06-27→ Common Stock (20,000 underlying)
20,000
Non-qualified Stock Options (right to buy)
Exercise: $7.61From: 2001-12-08Exp: 2011-12-08→ Common Stock (8,890 underlying)
8,890
Non-qualified Stock Options (right to buy)
Exercise: $21.67From: 2003-12-13Exp: 2013-12-13→ Common Stock (3,500 underlying)
3,500
Non-qualified Stock Options (right to buy)
Exercise: $15.03From: 2004-12-18Exp: 2014-12-18→ Common Stock (10,000 underlying)
10,000

Footnotes (7)

[F1]Represents plan holdings as of September 23, 2009.
[F2]Becomes exercisable in equal annual installments of 20% commencing 2/12/02.
[F3]Becomes exercisable in equal annual installments of 20% commencing 12/08/02.
[F4]Becomes exercisable in equal annual installments of 20% commencing 02/06/04.
[F5]Becomes exercisable in equal annual installments of 20% commencing 06/27/08.
[F6]Becomes exercisable in equal annual installments of 20% commencing 05/21/09.
[F7]The shares were sold at prices ranging from $17.76 to $18.01. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price

Documents

1 file